Hikma Pharmaceutical reported $349M in EBITDA for its first fiscal semester of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebitda Change
AstraZeneca AZN:LN USD 3.6B 404M
Bayer BAYN:GR EUR 2.45B 2.31B
Fresenius FRE:GR EUR 1.62B 142M
Fresenius Medical Care FMS:US EUR 810.48M 11.41M
Galapagos GLPG:NA EUR -31698000 12.18M
Hikma Pharmaceutical HIK:LN USD 349M 19M
Merck MRK:GR EUR 1.81B 14M
Orion ORNBV:FH EUR 257.4M 174.3M
Recordati REC:IM EUR 162.47M 7.47M
Roche Holding ROG:VX 13.44B 2.56B